Ladostigil hydrochloride is a dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO), with IC50 values of 37.1 μM for MAO-B and 31.8 μM for AChE; it exhibits neuroprotective, antioxidant, and anti-inflammatory effects and is used in research on depression and Alzheimer's disease; it also serves as a click chemistry reagent containing an alkyne group that undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules.